Respiratory News and Research

RSS

On-the-spot test aids postsurgical coagulopathy management

Point-of-care thromboelastometric and aggregometric testing helps to reduce exposure to allogenic blood products in patients with coagulopathy after cardiac surgery, a randomized trial shows.

5 Sep 2012

Arsenic induces acute promyelocytic leukemia remission

Elderly patients with acute promyelocytic leukemia have a high rate of response to arsenic trioxide, say researchers who believe the drug should be a first-line treatment in this population.

5 Sep 2012

More women and non-smokers being diagnosed with non-small cell lung cancer

There has been an increase in the number of non-smokers being diagnosed with non-small cell lung cancer, according to new findings.

5 Sep 2012

Exposure to natural disasters can prompt people to start smoking

The prevalence of smoking in Christchurch, New Zealand, increased following the 2010 earthquake, according to a new study.

5 Sep 2012

Children's asthma symptoms could be worse due to chaotic home environment

Parental problems and a chaotic home environment could be preventing children from taking their prescribed asthma medication.

5 Sep 2012

Sleep apnoea severity associated with increased cancer mortality

Sleep apnoea severity has been associated with increased cancer mortality in a new study.

5 Sep 2012

Smoker's pack-years, age and area of emphysema are strong predictors of mortality in COPD

Identifying an individual's the smoking history could help doctors to predict survival time in people with COPD.

5 Sep 2012

Exposure to volcanic ash increases respiratory symptoms

Exposure to volcanic ash can increase respiratory symptoms such as an extreme cough, or phlegm, according to a new study.

5 Sep 2012

First global benchmarks for assessing lung function across entire life span

New research has established the first global benchmarks for assessing lung function across the entire life span. The lung growth charts will help healthcare professionals better understand lung disease progression and help raise awareness of lung disease, which is the world's leading cause of death.

5 Sep 2012

Phase 1b trial validates efficacy of Pulmatrix PUR118 to treat COPD

Pulmatrix, Inc., a clinical stage biotechnology company creating novel inhaled therapeutics, today announced top line results from a clinical study showing that the novel inhaled therapeutic, PUR118, demonstrated anti-inflammatory efficacy and was well-tolerated in two Phase 1b studies in patients with chronic obstructive pulmonary disease (COPD).

5 Sep 2012

Predictors of early death after traumatic bleeding uncovered

The strongest predictors of early death after traumatic postinjury bleeding are Glasgow coma score, age, and systolic blood pressure, report researchers.

4 Sep 2012

EC grants marketing authorization for Pfizer’s INLYTA to treat renal cell carcinoma

Pfizer Inc. announced today that the European Commission (EC) has granted marketing authorization for INLYTA (axitinib) for the treatment of adult patients with advanced renal cell carcinoma (RCC), a type of kidney cancer, after failure of prior treatment with sunitinib or a cytokine.

4 Sep 2012

FDA approves Novartis’ Exelon Patch to treat mild to moderate AD

The US Food and Drug Administration has approved a higher dose of Exelon Patch (rivastigmine transdermal system) for the treatment of people with mild to moderate Alzheimer's disease.

4 Sep 2012

High-dose vitamin D appears to help patients with TB recover more quickly

For decades before antibiotics became generally available, sunshine was used to treat tuberculosis, with patients often being sent to Swiss clinics to soak up the sun's healing rays. Now, for the first time scientists have shown how and why heliotherapy might, indeed, have made a difference.

4 Sep 2012

$Noninvasive fractional flow reserve still out of reach$

Noninvasive fractional flow reserve still out of reach

A novel, noninvasive approach to determining fractional flow reserve failed to show sufficient diagnostic accuracy to meet the primary endpoint of the DeFACTO trial, but was more accurate for diagnosing coronary artery ischemia than computed tomography, reported the trial’s lead investigator.

3 Sep 2012

Novel scoring system shows sclerotherapy improves pain of venous malformation

Ethanol sclerotherapy reduces the signs and symptoms of venous malformation in the majority of patients after approximately two sessions, report Japanese researchers who used a novel scoring system to evaluate treatment outcomes.

3 Sep 2012

Obesity no barrier to knee replacement surgery

Health policy should not withhold total knee arthroplasty from patients on the basis of obesity, say UK researchers.

3 Sep 2012

Hospitalist-led ED reduces diversion, improves patient flow

Implementing a hospital medicine-led emergency department team could reduce the number of times such departments are forced to divert new patients because of a lack of beds, as well as improve patient flow, show study findings.

3 Sep 2012

New analyses from Esbriet RECAP study in IPF patients presented at ERS 2012

InterMune, Inc. announced that new analyses of data from the RECAP extension study of Esbriet (pirfenidone) were presented today at the 2012 Annual Congress of the European Respiratory Society (ERS) in Vienna, Austria by Dr. Ulrich Costabel of the Ruhrlandklinik, Essen, Germany.

3 Sep 2012

VIDA releases Apollo 1.2 SaaS for endobronchial emphysema treatment

VIDA Diagnostics, a leading developer of quantitative imaging analysis software for the diagnosis and treatment planning of major pulmonary disease, announced today the release and commercial availability of Apollo 1.2, here at the European Respiratory Society (ERS) meeting in Vienna, Austria.

3 Sep 2012